374 related articles for article (PubMed ID: 38397187)
1. NF-κB: Governing Macrophages in Cancer.
Cornice J; Verzella D; Arboretto P; Vecchiotti D; Capece D; Zazzeroni F; Franzoso G
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397187
[TBL] [Abstract][Full Text] [Related]
2. Tumor cells-derived conditioned medium induced pro-tumoral phenotypes in macrophages through calcium-nuclear factor κB interaction.
Zhang Y; Zhang Z; Chen L; Zhang X
BMC Cancer; 2022 Dec; 22(1):1327. PubMed ID: 36536301
[TBL] [Abstract][Full Text] [Related]
3. Revisiting of TAMs in tumor immune microenvironment: Insight from NF-κB signaling pathway.
He R; He Y; Du R; Liu C; Chen Z; Zeng A; Song L
Biomed Pharmacother; 2023 Sep; 165():115090. PubMed ID: 37390708
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.
Kono Y; Kawakami S; Higuchi Y; Yamashita F; Hashida M
Biol Pharm Bull; 2014; 37(1):137-44. PubMed ID: 24141263
[TBL] [Abstract][Full Text] [Related]
5. Increased OIT3 in macrophages promotes PD-L1 expression and hepatocellular carcinogenesis via NF-κB signaling.
Wen J; Yang S; Yan G; Lei J; Liu X; Zhang N; Zhang J; Deng H; Wu L; Li Y
Exp Cell Res; 2023 Jul; 428(2):113651. PubMed ID: 37201744
[TBL] [Abstract][Full Text] [Related]
6. Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer.
Hoover AA; Hufnagel DH; Harris W; Bullock K; Glass EB; Liu E; Barham W; Crispens MA; Khabele D; Giorgio TD; Wilson AJ; Yull FE
BMC Cancer; 2020 Oct; 20(1):970. PubMed ID: 33028251
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.
Yang D; Yang L; Cai J; Li H; Xing Z; Hou Y
Mol Cell Biochem; 2022 Oct; 477(10):2469-2480. PubMed ID: 35590082
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation.
Cho U; Kim B; Kim S; Han Y; Song YS
Mol Carcinog; 2018 Feb; 57(2):235-242. PubMed ID: 29024042
[TBL] [Abstract][Full Text] [Related]
9. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
[TBL] [Abstract][Full Text] [Related]
10. Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization.
Li M; Lai X; Zhao Y; Zhang Y; Li M; Li D; Kong J; Zhang Y; Jing P; Li H; Qin H; Shen L; Yao L; Li J; Dou K; Zhang J
Cell Death Dis; 2018 Feb; 9(2):248. PubMed ID: 29445150
[TBL] [Abstract][Full Text] [Related]
11. Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.
Gao Z; Li XG; Feng SR; Chen JF; Song K; Shi YH; Tang Z; Liu WR; Zhang X; Huang A; Luo XM; Zeng HY; Gao Q; Shi GM; Ke AW; Zhou J; Fan J; Fu XT; Ding ZB
Int Immunopharmacol; 2023 Oct; 123():110685. PubMed ID: 37494837
[TBL] [Abstract][Full Text] [Related]
12. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
13. Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer.
Glass EB; Hoover AA; Bullock KK; Madden MZ; Reinfeld BI; Harris W; Parker D; Hufnagel DH; Crispens MA; Khabele D; Rathmell WK; Rathmell JC; Wilson AJ; Giorgio TD; Yull FE
BMC Cancer; 2022 May; 22(1):497. PubMed ID: 35513776
[TBL] [Abstract][Full Text] [Related]
14. Lapachol inhibits the growth of lung cancer by reversing M2-like macrophage polarization via activating NF-κB signaling pathway.
Zhang Z; Bai L; Lu C; Li X; Wu Y; Zhang X; Shen Y
Cell Signal; 2023 Dec; 112():110902. PubMed ID: 37751828
[TBL] [Abstract][Full Text] [Related]
15.
Zhao T; Zhang Z; Li Y; Sun Z; Liu L; Deng X; Guo J; Zhu D; Cao S; Chai Y; Nikolaevna UV; Maratbek S; Wang Z; Zhang H
Front Immunol; 2023; 14():1180837. PubMed ID: 37325614
[TBL] [Abstract][Full Text] [Related]
16. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
Front Immunol; 2020; 11():1731. PubMed ID: 32849616
[TBL] [Abstract][Full Text] [Related]
17. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
Han Z; Wu X; Qin H; Yuan YC; Schmolze D; Su C; Zain J; Moyal L; Hodak E; Sanchez JF; Lee PP; Feng M; Rosen ST; Querfeld C
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427589
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
20. Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression.
Porta C; Ippolito A; Consonni FM; Carraro L; Celesti G; Correale C; Grizzi F; Pasqualini F; Tartari S; Rinaldi M; Bianchi P; Balzac F; Vetrano S; Turco E; Hirsch E; Laghi L; Sica A
Cancer Immunol Res; 2018 May; 6(5):578-593. PubMed ID: 29588321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
